Skip to content

Behavioral Weight Loss and Exercise After Treatment (BEAT)

Behavioral Weight Loss and Exercise After Treatment (BEAT): Predictors of Weight Loss Success in Overweight Breast Cancer Survivors

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02052115
Acronym
BEAT
Enrollment
80
Registered
2014-01-31
Start date
2014-01-31
Completion date
2016-12-31
Last updated
2014-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

breast cancer, exercise, weight loss, executive function, breast cancer survivor

Brief summary

Overweight and physically inactive breast cancer survivors are at increased risk of breast cancer recurrence and mortality. Cancer treatment-related changes that likely mediate weight loss and exercise success include the long term effects such as fatigue, psychological distress and impaired executive (cognitive) function. This study will explore the variability in how breast cancer survivors respond to a behavioral weight loss intervention. The primary objectives include determining the degree to which success with a behavioral weight loss intervention in overweight breast cancer survivors is explained by measures of executive function as measured with task performance at 6 and 12 months and associated brain function imaging (fMRI), collected at baseline only.Additionally, the study is designed to determine the degree to which selected measures of cancer-related symptoms account for variance in the success of breast cancer survivors at 6 and 12 months following entry into a behavioral weight loss and exercise intervention.

Interventions

BEHAVIORAL12 month exercise and weight loss intervention

Sponsors

National Institute of General Medical Sciences (NIGMS)
CollaboratorNIH
University of Vermont
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* Breast cancer diagnosis * Received surgery +/- chemotherapy +/- radiation for treatment of a Stage I, II or III breast cancer. Ongoing treatment with monoclonal antibodies and/or anti-estrogen therapy is acceptable * Completion of initial therapy 6 weeks prior to study initiation * BMI of 27-45 kg/m\^2

Exclusion criteria

* Prior diagnosis of malignancy other than non-melanoma skin cancer (i.e. prior non-melanoma skin cancer is not an

Design outcomes

Primary

MeasureTime frameDescription
Correlation of executive function and weight loss success12 monthsDetermine the degree to which success with a behavioral weight loss intervention in overweight breast cancer survivors is explained by measures of executive function, measured with task performance and associated brain function imaging (fMRI), at 6 and 12 months.

Secondary

MeasureTime frameDescription
Correlation of cancer related symptoms and weight loss12 monthsDetermine the degree to which selected measures of cancer-related symptoms account for variance in the success of breast cancer survivors at 6 and 12 months
Efficacy of a weight loss intervention12 monthsDetermine the effectiveness of a behavioral weight loss and exercise intervention

Countries

United States

Contacts

Primary ContactKim Dittus, MD, PhD
kim.dittus@vtmednet.org802-656-5470
Backup ContactKaren Wilson, CCRP
karen.m.wilson@uvm.edu802-656-4101

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026